Antidiabetic Activity of Eupatorin against Streptozotocin-Induced Diabetes in Rats: Biochemical and Histological Studies
Abdullah Farasani1,2★, Siddig Ibrahim Abdelwahab1★ Corresponding author
- 1Health Research Centre, Jazan University, Jazan, SAUDI ARABIA.
- 2College of Nursing and Health Science, Jazan University, Jazan, SAUDI ARABIA.
CORRESPONDENCE
Abdullah Farasani
Health Research Centre, Jazan University, Jazan, SAUDI ARABIA.
Received: 25-11-2024; Revised: 08-01-2024; Accepted: 15-04-2025.
Volume 59, Issue 3 · pp. 1160–1169 · PUBLISHED 2025 · DOI: 10.5530/ijper.20251812
ABSTRACT
Background: Diabetes mellitus is a persistent metabolic condition that has emerged as a major public health issue globally. The prevalence of diabetes has been rapidly increasing, posing a major challenge to global healthcare systems. Objectives: The present work was aimed at investigating the anti-diabetic roles of the eupatorin against Streptozotocin (STZ)-induced rat model. Materials and Methods: The rats received 55 mg/kg of STZ to induce diabetes and were then treated with eupatorin for 15 days. At the end of treatments, the blood glucose concentration of experimental rats was evaluated. The biomarkers for renal impairment, including urea and creatinine, serum concentrations of liver marker enzymes, serum levels of lipid profile parameters and oxidative stress markers were assessed with commercial assay kits. The pancreas, liver and kidneys of the rats were subjected to histological studies to assess histological alterations. Results: The current findings demonstrated that eupatorin treatment significantly decreased the blood glucose, urea and creatinine concentrations in the serum of diabetic rats. The eupatorin treatment also reduced the serum concentrations of liver marker enzymes, regulated the lipid profile parameters and mitigated the oxidative stress via up-regulating antioxidants in the rats with STZ-induced diabetes. Moreover, the findings of histological analyses show that eupatorin treatment can protect vital organs from diabetes-induced histopathological alterations in diabetic rats. Conclusion: The current findings indicate that eupatorin may significantly mitigate diabetic conditions and its associated difficulties in STZ-induced rats. Consequently, the current data suggest that eupatorin may serve as an effective therapeutic alternative for diabetes management.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Farasani, A., & Abdelwahab, S. I. (2025). Antidiabetic Activity of Eupatorin against Streptozotocin-Induced Diabetes in Rats: Biochemical and Histological Studies. Indian Journal of Pharmaceutical Education and Research, 59(3), 1160–1169. https://doi.org/10.5530/ijper.20251812